Enter your terms above and click the 'Search' button.

Showing articles 0 to 10 of 10 Filter Applied: myasthenia gravis,drug induced (Click to remove) Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 Acute demyelinating polyneuropathy induced by nivolumab JNNP 89:435-437, Fukumoto, Y.,et al, 2018 Drugs and Myasthenia Gravis, An Update Arch Int Med 157:399-408, Wittbrodt,E.T., 1997 Treatment of Acquired Myasthenia Gravis Neurol 48 (Suppl 5) :S46-S51997., Massey,J.M., 1997 Ocular Myasthenia:A Protean Disorder Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994 Ocular Myasthenia Gravis J Natl Med Assoc 85:681-684, March,G.A.&Johnson,J.N., 1993 Aggravation of Myasthenia Gravis by Erythromycin J Pediatr 119:155-156, Absher,J.R.&Bale,J.F., 1991 Aggravation of Myasthenia Gravis by Erythromycin Ann Neurol 28:577-579, May,E.F.&Calvert,P.C., 1990 Adverse Drug Effects on Neuromuscular Transmission Semin Neurol 10:89-102, Howard,J.F., 1990 Disorders of Neuromuscular Transmission Caused by Drugs NEJM 301:409-413, Argov,Z.,et al, 1979 Showing articles 0 to 10 of 10